Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Dose-Escalation, Pilot Study of PRT-201 Administered Following Angioplasty in Patients With Peripheral Artery Disease in the Lower Extremity

NCT01616290 is registered in ClinicalTrials.gov with Proteon Therapeutics as lead sponsor.

NCT NCT01616290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01616290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Dose-Escalation, Pilot Study of PRT-201 Administered Following Angioplasty in Patients With Peripheral Artery Disease in the Lower Extremity
Lead sponsor
Proteon Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2012
Completion date
July 31, 2015
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease